FDA Enforcement Class II Terminated

GE Healthcare Senographe Essential System. The Senographe 2000D system generates digital mamnmographic images that can be used for screening and in the diagnosis of breast cancer. The Senographe 2000D is intended to be used in the same clinical applications as traditional film-based mamnmographic systems.

Recall: Z-1519-2013 · Reported July 3, 2013

Enforcement

Recall Number
Z-1519-2013
Event ID
65372
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
GE Healthcare, LLC
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
July 3, 2013
Initiation Date
January 14, 2013
Classification Date
June 26, 2013
Termination Date
November 26, 2013
Address
3000 N Grandview Blvd, Waukesha, WI, 53188-1615, United States

Description

GE Healthcare Senographe Essential System. The Senographe 2000D system generates digital mamnmographic images that can be used for screening and in the diagnosis of breast cancer. The Senographe 2000D is intended to be used in the same clinical applications as traditional film-based mamnmographic systems.

Reason

GE Healthcare has recently become aware of a potential issue due to inaccessible Operator Instructions associated with the defective Operator Manual CD of the Senographe Essential.

Code Info

Models 5144816-10 rev 2, 3 or 6 and 5144816-10-LE rev1.

Distribution

Nationwide Distribution including the states of NJ, CO, LA, AL, OH, MA, NC, ME, WI, GA, PA, TX, IN, NY, MO, KY, KS, CA, MN, FL and IL.

Quantity

49 installed in the US.